Make Up for Lost Time and Money: Using the Lanham Act to Regulate the Cosmetic Industry by Monastra, Maria
William & Mary Business Law Review
Volume 9 | Issue 2 Article 9
Make Up for Lost Time and Money: Using the
Lanham Act to Regulate the Cosmetic Industry
Maria Monastra
Copyright c 2018 by the authors. This article is brought to you by the William & Mary Law School Scholarship Repository.
https://scholarship.law.wm.edu/wmblr
Repository Citation
Maria Monastra, Make Up for Lost Time and Money: Using the Lanham Act to Regulate the Cosmetic
Industry, 9 Wm. & Mary Bus. L. Rev. 521 (2018), https://scholarship.law.wm.edu/wmblr/vol9/
iss2/9
521 
 
MAKE UP FOR LOST TIME AND MONEY: USING 
THE LANHAM ACT TO REGULATE THE 
COSMETIC INDUSTRY 
MARIA MONASTRA* 
ABSTRACT 
In recent years, the cosmetic industry has experienced an 
increase in litigation brought on by consumers in their efforts to 
protect themselves from cosmetics that are either unsafe or falsely 
advertised. The Supreme Court of the United States’ discussion in 
POM Wonderful v. Coca-Cola Co. of the Lanham Act, the United 
States’ principal false advertising statute, clarified the breadth 
and depth of allowable lawsuits brought under the statute in mat-
ters which also concern the Food, Drug, & Cosmetic Act (FDCA). 
The case centered on a detailed discussion of the issue of federal 
preemption. Although the decision directly involved only the food 
and drug manufacturing industry, the Court’s holding appears 
to promote an expanded use of the Lanham Act generally, and 
conjunctively, in industries otherwise regulated by the Food and 
Drug Administration. This Note will examine the ways in which 
the cosmetic industry will be affected if its manufacturers appro-
priately apply the Court’s holding in POM Wonderful v. Coca-Cola 
Co. to their own issues of false advertising and consumer dissat-
isfaction. Furthermore, the shortcomings of traditional consumer 
protection lawsuits are discussed before I argue that both con-
sumers and manufacturers of cosmetics would fare better if the 
cosmetic industry’s legal issues were resolved by and between those 
with capital interests in the cosmetics themselves. 
                                                                                                            
* The author is a JD Candidate at William & Mary Law School. She owes many 
thanks to the William & Mary Business Law Review editorial board and staff 
for their hard work and reflective contributions. She is grateful for the constant 
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INTRODUCTION 
 Every day, American consumers purchase cosmetics from 
retailers across the country without knowing the extent to which 
those cosmetics are—or are not—regulated by the government.1 
The Food and Drug Administration (FDA) is the government 
agency responsible for protecting American consumers from harm-
ful cosmetics and personal care products.2 The United States 
government delegated the power, albeit minimal,3 to regulate the 
safety and proper labeling of cosmetics sold in interstate com-
merce to the FDA in 1938 via the Federal Food, Drug, and Cos-
metic Act (FDCA).4 The FDCA consists of 112 pages of standards 
applicable to food and drug safety, but dedicates only one page 
to cosmetics.5 The FDA is neither responsible for approving cos-
metic products before they are released to the goods market, nor 
capable of requiring product recalls or injury reports relating to 
cosmetics after their release.6 As a result, most safety standards 
that apply to and constrain cosmetic manufacturers are imposed 
by the manufacturers themselves. All this leads to an industry 
that is almost entirely self-regulated.7 
 Recent estimates value the cosmetic industry at $71 billion.8 
When compared to the industry’s aggregate size and wealth, claims 
of injuries caused by cosmetics have been too rare and indeter-
minate for manufacturers and other industry representatives to 
find increased government oversight imperative.9 They argue 
                                                                                                            
1 Natasha Singer, Skin Deep; Should You Trust Your Makeup?, N.Y. TIMES 
(Feb. 15, 2007), http://query.nytimes.com/gst/fullpage.html?res=9A02E0DF17 
3EF936A25751C0A9619C8B63&pagewanted=all. 
2 See Cosmetics Basics, FOOD & DRUG ADMIN. (last updated July 7, 2017), 
http://wayback.archive-it.org/7993/20171114064614/https://www.fda.gov/About 
FDA/Transparency/Basics/ucm193940.htm [https://perma.cc/J2CT-QE6F]. 
3 See infra Part I. 
4 See Cosmetics Basics, supra note 2; see also Federal Food, Drug & Cosmetic 
Act, 21 U.S.C. § 301 (2012). 
5 U.S. Laws: FDA’s Lack of Authority, CAMPAIGN FOR SAFE COSMETICS, http:// 
www.safecosmetics.org/get-the-facts/regulations/us-laws/ [https://perma.cc/VL3G 
- 39MX] (last visited Feb. 19, 2018). 
6 See id. 
7 See id. 
8 See id. 
9 See Singer, supra note 1. 
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instead for increased self-regulation.10 Many legal actions pursued 
against cosmetic manufacturers are brought by consumers who rely 
on theories of false or misleading advertising.11 The federal statute 
under which claims of false or misleading promotional statements 
are litigated is Section 43(a) of the Lanham Act,12 but Section 43(a) 
generally excludes consumers.13 The statute instead grants stand-
ing to commercial competitors whose business interests are in-
fringed upon or who suffer market dilution as a result of false or 
misleading advertising.14 As a result, in most circumstances, con-
sumers whose injuries are personal rather than commercial are left 
only with standing to pursue state court consumer fraud actions. 
 A recent United States Supreme Court decision, POM 
Wonderful v. Coca-Cola Co., relaxed the prohibited uses of the 
Lanham Act in situations where its application coincides with 
the FDA’s primary enforcement responsibilities.15 The decision 
allowed an action brought under the Lanham Act to complement 
the FDA’s enforcement of the FDCA.16 One positive side effect of 
the decision is that it facilitates the statute’s goals of preserving 
free market competition and prohibiting anticompetitive behav-
ior through false advertising.17 This Note aims to demonstrate 
that use of the Lanham Act by commercial competitors in the 
cosmetic industry is the appropriate solution to the industry’s quest 
for increased self-regulation and to consumers’ search for protec-
tion from potentially harmful products. Expanding the Lanham 
Act’s use in this way will effectively mend decades of insufficient 
federal oversight of the cosmetic industry. 
 Part I of this Note provides an overview of the obstacles 
unique to maintaining a successful cosmetic business and the 
                                                                                                            
10 Id. 
11 See infra Sections I.A–B. 
12 See Harold Weinberger, Jonathan Wagner & Tobias Jacoby, 9 Key Ques-
tions About Lanham Act False Advertising Suits, CORP. COUNS. (Mar. 26, 2012). 
13 Id. 
14 See id. 
15 See POM Wonderful LLC v. Coca-Cola Co., 134 S. Ct. 2228, 2231 (2014). 
16 Id. at 2238 (explaining “[t]he Lanham Act and the FDCA complement each 
other in major respects, for each has its own scope and purpose. Although both 
statutes touch on food and beverage labeling, the Lanham Act protects commer-
cial interests against unfair competition, while the FDCA protects public health 
and safety”). 
17 See generally id. at 2238–39. 
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common legal claims brought against cosmetics manufacturers. 
Part II introduces and explains the Federal FDCA; the Lanham 
Act; and the Supreme Court’s holding in POM Wonderful v. Coca-
Cola Co. Part III explores the application of the Lanham Act to 
the cosmetic industry after POM Wonderful and discusses the 
benefits that will result from such application including safer cos-
metic ingredients and more profitable niche cosmetic companies. 
Such benefits include a more efficient marketplace where consum-
ers are kept safe from harmful cosmetics and their expectations 
of honest marketing are met, and cosmetic companies offering 
niche products have an avenue to hold their own against their 
larger competitors.18 
I. ISSUES UNIQUE TO THE COSMETIC INDUSTRY’S BUSINESS 
A. Changing Consumer Preferences 
 In 2016, statisticians estimated that the revenue generated 
by the cosmetic industry in the United States alone would reach 
$62.46 billion.19 Even more recently, a Forbes contributor noted 
that the industry’s global sales amount to $445 billion.20 The 
reasons why Americans invest so heavily in personal care cos-
metics and beauty products are outside the scope of this Note.21 
                                                                                                            
18 See infra Part III. 
19 See Revenue of the Cosmetic/Beauty Industry in the United States from 
2002 to 2016, STATISTA (2017), https://www.statista.com/statistics/243742/revenue 
-of-the-cosmetic-industry-in-the-us/ [https://perma.cc/W7ST-KNPH] [hereinaf-
ter Revenue of the Cosmetic Industry]; see also Statistics and Facts on the U.S. 
Cosmetics and Makeup Industry, STATISTA (2017), https://www.statista.com 
/topics/1008/cosmetics-industry/ [https://perma.cc/38XU-F5WD] [hereinafter 
Statistics & Facts]. 
20 Chloe Sorvino, Why the $445 Billion Beauty Industry is a Gold Mine for 
Self-Made Women, FORBES (May 17, 2017), https://www.forbes.com/sites/chloe 
sorvino/2017/05/18/self-made-women-wealth-beauty-gold-mine/#744f4e092a3a 
[https://perma.cc/G97E-4ZVX]. 
21 See, e.g., Olga Khazan, Why Do So Many Women Wear So Much Makeup?, 
ATLANTIC (Apr. 28, 2014), http://www.theatlantic.com/health/archive/2014/04 
/women-wear-too-much-makeup-because-they-mistakenly-think-men-want-them 
-to/361264/ [https://perma.cc/98NS-24V7] (noting that makeup preferences may 
be tied to the misperceived expectancies of men); Kim Carollo, Makeup Makes 
Women Seem More Competent, Study Says, ABC NEWS (Oct. 4, 2011), http://abc 
news.go.com/Health/cosmetics-make-women-likable-competent-trustworthy 
 
526 WILLIAM & MARY BUSINESS LAW REVIEW [Vol. 9:521 
Personal cosmetics investments are relevant only insofar as they 
indicate the aggregate enormity and permanence of the industry.22 
The potential to capitalize on the average American’s interest in 
beauty and personal care cannot be overstated in such a high-
grossing industry.23 As of 2015, industry leaders worldwide included 
Unilever (i.e., Dove’s parent company), Proctor & Gamble, Estée 
Lauder, and L’Oreal.24 L’Oreal topped the list with the number 
one spot and the most coveted of revenues—$29.94 billion.25 It is 
no surprise that smaller companies are attempting to penetrate 
the stronghold of household names with niche products tailored 
to current trends of consumption in the cosmetic industry.26 
 Consumers in today’s cosmetic market increasingly care 
about the content of their personal care products and the practices 
employed to manufacture them.27 They care particularly about the 
safety and ethical soundness of the cosmetics they purchase.28 
Such preferences led to what is now commonly referred to as the 
“natural beauty market.”29 Natural beauty product manufacturers 
                                                                                                            
-attractive-study/story?id=14659706 [https://perma.cc/F7HE-JMLS] (noting 
that cosmetics could impact how women are perceived beyond their physical 
attractiveness). 
22 See Revenue of the Cosmetic Industry, supra note 19. 
23 Id. 
24 Soma Dutta, Top 10 Best Cosmetic Companies in the World, INSIDER 
MONKEY (Nov. 6, 2015), http://www.insidermonkey.com/blog/top-10-best-cosmetic 
-companies-in-the-world-381313/ [https://perma.cc/9B6V-HRGY]. 
25 Id. 
26 Beth Shapouri, The Way We Buy Beauty Now, RACKED (May 26, 2016), 
http://www.racked.com/2016/5/26/11674106/buying-beauty-sephora-department 
[https://perma.cc/V3MZ-CBXY] (commenting “[t]he door is opening wider to 
specialty, niche, and indie lines.”); see also Sorvino, supra note 20. 
27 See Meryl C. Maneker & Vickie E. Turner, Cosmetics and Beauty Product 
Litigation, PRAC. LAW. 29, 38 (2013) (noting that “[t]he natural beauty market is 
one of the fastest growing segments of the overall personal care products market”). 
28 These consumer preferences are evidenced by the existence and rising pop-
ularity of companies like Lush Cosmetics and Pacifica Beauty. Lush Cosmet-
ics is committed to naked packaging, vegetarian manufacturing, fresh, handmade 
ingredients, ethical buying, and fighting animal testing. See Our Values, LUSH, 
http://www.lushusa.com/on/demandware.store/Sites-Lush-Site/en_US/Page-View 
?cid=our-values-2014 [https://perma.cc/4HYF-UTGT] (last visited Feb. 19, 2018). 
Pacifica sells only gluten-free, 100% vegan, and cruelty-free products. See 
PACIFICA, Our Products, http://www.pacificabeauty.com/our-products [https:// 
perma.cc/TNJ2-9PXS] (last visited Feb. 19, 2018). 
29 See Maneker & Turner, supra note 27, at 29, 38. 
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aim to infiltrate the billion-dollar cosmetic industry with prod-
ucts that are free from harmful chemicals and manufactured with 
a conscience—that is, made with animal safety and other envi-
ronmental concerns at the forefront of production.30 Like most 
boutiques that offer a niche commodity or service, small, specialty 
cosmetic companies compete with recognizable household brands 
by narrowly tailoring their advertising and manufacturing prac-
tices to meet the needs of a modern, socially conscious consumer.31 
To this end, those small, specialty cosmetic companies have to 
charge more for their products because their production costs are 
“2 to 3 times higher” than those of the industry conglomerates.32 
 Consumers of cosmetics in the millennial age have also 
shown that they prefer products that give them a sense of indi-
viduality;33 by extension, cosmetic retailers that carry a “selection 
of niche, under-the-radar brands” have been able to dramatically 
increase their profits, their number of overall store transactions, 
and the value of their transactions.34 Moreover, millennial con-
sumers tend not to show loyalty to any particular brands; they 
instead prefer to approach the process of purchasing cosmetics like 
                                                                                                            
30 See, e.g., Our Story, LUSH, http://www.lushusa.com/Stories-Show?tag=our 
-story [https://perma.cc/8FLD-CWBQ] (last visited Feb. 19, 2018); PACIFICA, 
http://www.pacificabeauty.com/ [https://perma.cc/JL5C-RSTS] (last visited Feb. 19, 
2018); see also James Russo, Package This: Beauty Consumers Favor ‘Cruelty-Free’ 
and ‘Natural’ Product Claims, NIELSEN (March 24, 2015), http://www.nielsen.com 
/us/en/insights/news/2015/package-this-beauty-consumers-favor-cruelty-free-and 
-natural-product-claims.html [https://perma.cc/A3WU-ZDL2]. 
31 The “organic channel” of cosmetics saw a twenty four percent growth rate 
over the past four years, and the increase is likely attributable to a “growing 
distrust” of chemicals. Shapouri, supra note 26. 
32 Perry Romanowski, Can small cosmetic companies be successful?, CHEMISTS 
CORNER (2017), http://chemistscorner.com/can-small-cosmetic-companies-be-suc 
cessful/ [https://perma.cc/HMJ2-FGHW]. For illustration, a 4 oz. bar of soap sold 
by Dove costs approximately $1.32, TARGET, Dove White Beauty Bar?4oz/4pk, 
https://www.target.com/p/dove-white-beauty-bar-4oz-4pk/-/A-11223389 [https:// 
perma.cc/5KTW-7BAK] (last visited Feb. 19, 2018) (listing a package of four bars 
for $5.29); conversely, a 3.5 oz. LUSH bar of soap is priced between $6.95–$15.95, 
LUSH, Soap, http://www.lushusa.com/shower/soap/ [https://perma.cc/U2N4-VCGS] 
(last visited Feb. 19, 2018). 
33 Sarah Halzack, The Sephora effect: How the cosmetics retailer transformed 
the beauty industry, WASH. POST (Mar. 9, 2015), https://www.washingtonpost 
.com/news/business/wp/2015/03/09/the-sephora-effect-how-the-cosmetics-retailer 
-transformed-the-beauty-industry/ [https://perma.cc/2KQP-2DQK]. 
34 Id. 
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a “treasure hunt,”35 or a “playground for consumers,”36 because this 
approach makes them feel independent in the decision-making 
process.37 Modern consumers appreciate the opportunity to search 
the retailer’s offerings and test as many contending products as he 
or she likes before making the ultimate decision to purchase.38 
 It is not only the contents of cosmetics and the possibility 
of experimenting with them in-store that consumers consider prior 
to purchasing.39 Consumers use sources like online reviews, beauty 
blogs, and YouTube to influence their decisions to buy.40 With 
consumers actively searching for product information, and internet 
technology available to facilitate a seemingly infinite search field, 
the value of honest marketing cannot be overstated.41 Consumers 
want those responsible for advertising and labeling their favorite 
products to be mindful of their health needs and other expecta-
tions.42 A wave of litigation targets how specific contents of cos-
metics are marketed and how terms such as “natural” which are 
undefined by statute or common law but which are colloquially 
meaningful are used to describe a product quality.43 Lawsuits of 
this kind are on the rise, and courts’ decisions are complicated by 
the fact that the term “natural” has not yet been defined by the 
FDA.44 That the FDA has neglected to provide official guidance 
                                                                                                            
35 Id. 
36 Shapouri, supra note 26. 
37 See id. 
38 Id. 
39 See Maneker & Turner, supra note 27, at 38 (“[Cosmetics] are being closely 
examined for how they are marketed.”). 
40 Shapouri, supra note 26. 
41 See id. 
42 See, e.g., Brown v. Hain Celestial Grp., Inc., 913 F. Supp. 2d 881, 884 (N.D. 
Cal. 2012) (plaintiffs sued cosmetic manufacturer for falsely marketing certain of 
their products as organic). 
43 See id. at 885; see also Astiana v. Hain Celestial Grp., Inc., 783 F.3d 753, 
756 (9th Cir. 2015) (plaintiff sued when a product that was labeled “natural” 
was actually chock-full of synthetic ingredients). 
44 FOOD & DRUG ADMIN., SMALL BUSINESSES & HOMEMADE COSMETICS: FACT 
SHEET (last updated Oct. 5, 2016), http://www.fda.gov/Cosmetics/Resources 
ForYou/Industry/ucm388736.htm [https://perma.cc/U2N4-VCGS] (“FDA has not 
defined the term ‘natural’ and has not established a regulatory definition for 
this term in cosmetic labeling. FDA also does not have regulations for the term 
‘organic’ for cosmetics.”). 
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on the term’s meaning is one example of the agency’s minimal 
involvement in the cosmetic industry’s regulatory efforts.45 If an 
industry conglomerate falsely markets ingredients without much 
risk that a court will administer an injunction against it, that 
company will presumably be able to sell low-grade products at a 
low price, all while consumers rely on the product’s purported 
quality when making their purchases.46 Those injured by the 
largely self-regulated cosmetic industry ought to have the bene-
fit of a legal scheme which grants bona fide manufacturers an 
opportunity to compete for a portion of the industry’s billion-dollar 
revenues.47 If less harmful products made without synthetic ingre-
dients are what consumers want, these products should be easily 
discernible in the marketplace.48 
B. Claims Asserted Against Beauty Product Manufacturers 
1. Products Liability 
 In any products liability action, the plaintiff bringing the 
claim of defect has the burden of proving “that the injury-causing 
product was defective, that the defect existed at the time the 
product left the control of the defendant, and that such defect 
[was] the proximate cause of the plaintiff’s injury.”49 Consumers 
harmed by cosmetics, beauty products, and other personal care 
products have brought legal claims under traditional product lia-
bility theories in order to recover from negligent cosmetic manu-
facturers.50 In 2007, a plaintiff purchaser sued the manufacturer 
                                                                                                            
45 Id. (“The law does not require cosmetic products and ingredients, except 
for color additives, to be approved by FDA before they go on the market.”); see 
U.S. Laws: FDA’s Lack of Authority, CAMPAIGN FOR SAFE COSMETICS, http:// 
www.safecosmetics.org/get-the-facts/regulations/us-laws/ [https://perma.cc 
/VL3G-39MX] (last visited Feb. 19, 2018) (FDA cannot require product recalls, 
require manufacturers to register their cosmetic establishments, or require 
manufacturers to report cosmetic-related injuries). 
46 See infra Section I.B.2. 
47 See Revenue of the Cosmetic Industry, supra note 19. 
48 See generally Russo, supra note 30. 
49 AM. L. PROD. LIAB. 3D, Elements of actions involving defect, § 3:1, Westlaw 
(database updated Nov. 2017). 
50 See, e.g., Koronthaly v. L’Oreal USA, Inc., No. 08-4625, 2010 WL 1169958, 
at *1–2 (3d Cir. Mar. 26, 2010); Frye v. L’Oreal USA, Inc., 583 F. Supp. 2d 954, 
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of the hair texturizer in question on a failure-to-warn theory, 
alleging that the product had negatively affected her scalp.51 
The plaintiff claimed that the staph infection she suffered after 
using the “Soft and Beautiful Botanicals Texturizer” manufac-
tured by the defendant was a result of the defendant’s failure to 
instruct users to conduct a scalp test prior to using its product.52 
The Supreme Court of Louisiana overturned lower courts’ rul-
ings for the plaintiff and found instead that the plaintiff did not 
satisfy her burden of proving that “the manufacturer failed to use 
reasonable care to provide an adequate warning of such a [dan-
gerous] characteristic to users and handlers of the product.”53 
 A year later, an individual consumer brought a putative 
class action against L’Oreal on behalf of herself and others simi-
larly situated for the presence of lead in her lipstick.54 In that case, 
the plaintiff’s inability to prove any actual injury made the harm 
she suffered merely theoretical, and the court found irrelevant the 
fact that she would not have purchased the lipstick if she had 
known it contained lead.55 The court noted that the plaintiff needed 
to allege “observable economic consequences” from the presence of 
lead in her L’Oreal Colour Riche lipstick in order to establish and 
recover any damages.56 Another class action plaintiff filed a sim-
ilar complaint in 2010, claiming both that her lipstick was unac-
ceptable and unsafe because of the amount of lead it contained, 
and that she was misled into purchasing it by the defendants, 
L’Oreal and Proctor & Gamble.57 The plaintiff was unable to show 
liability on the part of the defendants because she asserted noth-
ing more than “subjective allegation[s]”58 and failed to show an 
“injury-in-fact sufficient to confer Article III standing.”59 Article III 
                                                                                                            
958–59 (N.D. Ill. 2008); Jack v. Alberto-Culver USA, Inc., 949 So. 2d 1256, 
1259 (La. 2007). 
51 Alberto-Culver USA, Inc., 949 So. 2d at 1256–57. 
52 Id. at 1257. 
53 Id. at 1259 (quoting LA. STAT. ANN. § 9:2800.57 (1988)) (brackets in original). 
54 Frye, 583 F. Supp. 2d at 956–57. 
55 Id. at 957–58. 
56 Id. 
57 Koronthaly v. L’Oreal USA, Inc., No. 08-4625, 2010 WL 1169958, at *1–2 
(3d Cir. Mar. 26, 2010). 
58 Id. 
59 Id. 
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standing is the constitutional requirement that a party seeking to 
sue must have “personally suffered some actual or threatened 
injury that can fairly be traced” to the defendant’s actions and 
show “that the injury is likely to be redressed by a favorable 
decision.”60 The court elaborated that a proper demonstration of 
factual injury in this case would have required an allegation from 
the plaintiff that “she received a product that failed to work for 
its intended purpose or was worth objectively less than what one 
could reasonably expect[.]”61 In both cases, the plaintiffs’ allega-
tions of injuries resulting from lead in their lipstick fell short of 
convincing the courts to award damages.62 
 The cases explored above provide a glimpse into the myriad 
challenges consumers face when they attempt to sue a large cos-
metic manufacturer, whether as an individual litigant or as a 
representative of a larger putative class.63 The primary hurdle 
consumers face in these cases varies from a lack of standing to a 
lack of evidence, but the moral of each case is the same: consum-
ers do not want to purchase defective cosmetics and obtaining re-
dress for their alleged injuries when they do is nearly impossible.64 
These cases suggest that the problems unique to the cosmetic 
industry are better addressed outside of the sphere of consumer 
protection, in which alleged injuries are perceived as too insignif-
icant or unsubstantiated to matter.65 
 Richard Levick has characterized the rise in cosmetic-
related lawsuits in recent years as a “litigation albatross.”66 At the 
                                                                                                            
60 Legal Information Institute, Constitutional Standards, Injury-in-Fact, 
Causation and Redressability, CORNELL U.L. SCH., https://www.law.cornell 
.edu/anncon/html/art3frag17_user.html [https://perma.cc/P2JM-EYDV] (last 
visited Feb. 19, 2018). 
61 Koronthaly, 2010 WL 1169958 at *2. 
62 Id. at *1–2; Frye v. L’Oreal USA, Inc., 583 F. Supp. 2d 954, 959 (N.D. 
Ill. 2008). 
63 See Koronthaly, 2010 WL 1169958 at *2; Frye, 583 F. Supp. 2d at 958–59; 
Jack v. Alberto-Culver USA, Inc., 949 So.2d 1256, 1259 (La. 2007). 
64 See Koronthaly, 2010 WL 1169958 at *2; Frye, 583 F. Supp. 2d at 958–59; 
Alberto-Culver, 949 So.2d at 1259. 
65 See Koronthaly, 2010 WL 1169958 at *2; Frye, 583 F. Supp. 2d at 958–59; 
Alberto-Culver, 949 So.2d at 1259. 
66 Richard Levick, ‘Nailed’: The Cosmetics Industry Is Next on the Firing 
Line, FORBES (May 15, 2015), http://www.forbes.com/sites/Richardlevick/2015 
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same time, he acknowledges certain allegations linking cosmetic 
ingredients to “cancer, miscarriages, birth defects, skin diseases, 
[and] other dangers.”67 Between the increased litigation and height-
ened awareness of potential risks, it is easy to see how public 
opinion might vary on the importance of a cosmetic industry that 
manufactures high-quality, safe products.68 Some of the public 
perceives cosmetic-related lawsuits as indicative of nothing more 
than an unbridled distrust of chemicals in the traditionally litigious 
consumer base of the American marketplace.69 Others have con-
cerns that the issues raised by recent consumer claimants are 
legitimate.70 Still others, as this Note suggests, believe that the 
solution to an industry riddled with misleading products is to shift 
the burden of obtaining judicial redress to commercial plaintiffs, 
namely cosmetic companies who have standing to sue under the 
Lanham Act and who have greater resources available to pursue 
a legal remedy than the average consumer.71 
2. Misleading Marketing 
 It should come as no surprise that consumers of cosmetic 
commodities, like consumers of most other commodities, look to the 
price of a good as a significant metric for predicting quality, which 
                                                                                                            
/05/19/nailed-the-cosmetics-industry-is-next-on-the-firing-line/#11cee8ba5f11 
[https://perma.cc/V9QV-M8NS]. By referring to cosmetic litigation as a “litigation 
albatross,” Levick intends to communicate the annoying burden these lawsuits 
impose on defendants. See Albatross Around One’s Neck, DICTIONARY.COM, http:// 
www.dictionary.com/browse/albatross-around-one-s-neck [https://perma.cc 
/XHE7-2759?type=image] (last visited Feb. 19, 2018). 
67 Levick, supra note 66. 
68 See id. 
69 See Cheryl Wischhover, Your Beauty Products Are Not Killing You, RACKED 
(May 5, 2016), http://www.racked.com/2016/5/5/11591300/natural-skincare-clean 
-beauty-toxins [https://perma.cc/AWM7-KL7V]. 
70 See CAMPAIGN FOR SAFE COSMETICS, ANTI-AGING SECRETS EXPOSED: 
CHEMICAL LINKED TO BREAST CANCER IN SKIN CARE at 5–6 (Oct. 2015), http:// 
www.safecosmetics.org/wp-content/uploads/2015/10/Anti-aging-secrets-exposed 
-report.pdf [https://perma.cc/R6GA-XKNY]; CAMPAIGN FOR SAFE COSMETICS, 
PRETTY SCARY 2: UNMASKING TOXIC CHEMICALS IN KIDS’ MAKEUP at 6–7 (Oct. 
2016), http://www.safecosmetics.org/wp-content/uploads/2016/10/Pretty-Scary 
_2016.pdf [https://perma.cc/N2ZW-BNFP]. 
71 See infra Part II. 
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guides the decision to purchase.72 Cosmetics are often offered at 
a premium based on the promises their labels purport to consumers. 
Consumers have litigated individually and as members of puta-
tive classes in an effort to combat the unreasonable and reckless 
use of misleading terms on cosmetic product packaging.73 
 In 2016, two California plaintiffs filed a class action alleg-
ing that a cosmetic manufacturer’s “use of the word ‘Natural’ on 
some of its products’ packaging [was] misleading because the 
products contain[ed] synthetic ingredients.”74 The Ninth Circuit 
found that the plaintiffs satisfied the requirements of pleading 
fraud with “particularity”75 to such extent that they were enti-
tled to proceed with their claims.76 
 Around the same time that the Ninth Circuit made their 
decision in Balser, a Legal News Line contributor observed that 
claims against cosmetic manufacturers for the use of words such 
as “natural” or “organic” on their products were on the rise.77 He 
added that the increase in this type of litigation may be attributed 
partly to the ambiguity surrounding such words.78 
 In a subsequent Ninth Circuit opinion, the plaintiff sued a 
cosmetic company for a “label, tube design, and packaging” that 
were “deceptive and misleading.”79 Specifically, the plaintiff’s alle-
gations were that the cosmetic manufacturer’s lip product was 
                                                                                                            
72 Anneli Rufus, The Cosmetics Racket: Why the Beauty Industry Can Get Away 
with Charging a Fortune for Makeup, ALTERNET (Sept. 10, 2010), http://www.al 
ternet.org/story/148140/the_cosmetics_racket%3A_why_the_beauty_industry_can 
_get_away_with_charging_a_fortune_for_makeup [https://perma.cc/ECR2-9T3Q]. 
73 See Balser v. Hain Celestial Grp., Inc., 640 F. App’x. 694, 695–96 (2016); 
Ebner v. Fresh, Inc., 838 F.3d 958, 961 (9th Cir. 2016); Elkind v. Revlon Con-
sumer Prod. Corp., No. 14-CV-2484(JS)(AKT), 2015 WL 2344134, at *9 (E.D.N.Y. 
May 14, 2015). 
74 Balser, 640 F. App’x. at 695. 
75 FED. R. CIV. P. 9(b). 
76 Balser, 640 F. App’x. at 695–96. 
77 Jacob Bielanski, Attorney: Guidance needed for cosmetic industry to avoid 
litigation, LEGAL NEWS LINE (Mar. 17, 2016), http://legalnewsline.com/stories 
/510699065-attorney-guidance-needed-for-cosmetics-industry-to-avoid-litigation 
[https://perma.cc/7JSQ-NAR5]. 
78 Id. Bielanski briefly discusses that legal questions concerning cosmetic 
products and how they are marketed require courts and juries to address what 
the “‘reasonable consumer’ would interpret.” Id. 
79 Ebner v. Fresh, Inc., 838 F.3d 958, 961 (9th Cir. 2016). 
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sold in “vastly oversized tubes,” which created the impression that 
consumers would receive a greater quantity of the lip product 
than they actually did.80 The amount of lip product that was “rea-
sonably accessible to the consumer” was allegedly only 75% of 
the container’s total volume.81 Despite these allegations, the Ninth 
Circuit affirmed the district court’s dismissal of the plaintiff’s 
claims for misleading or deceptive marketing.82 
 Misleading marketing claims of this type have their share 
of procedural limitations,83 including issues of primary jurisdic-
tion and federal preemption.84 In 2015, two plaintiffs sued Revlon 
for deceiving consumers via its use of the phrase “Age-Defying 
with DNA Advantage” on certain foundation, powder, and concealer 
products.85 The United States District Court for the Eastern Dis-
trict of New York found that plaintiffs’ mislabeling claims did 
not “squeak through the ‘narrow gap through which a plaintiff’s 
state-law claim must fit if it is to escape express or implied pre-
emption.’”86 Rather, the claims arose “because Plaintiffs allege[d] 
that the Powder and the Concealer violate[d] the FDCA, and prose-
cuting that violation lies squarely within the province of the FDA.”87 
 Having found the plaintiffs’ claims of mislabeling federally 
preempted, the court dismissed two counts of the complaint with 
prejudice.88 The court, however, declined to apply the doctrine of 
primary jurisdiction, “a matter of judicial prudence which provides 
that the courts should not mettle in claims where the enforcement 
                                                                                                            
80 Id. at 962. 
81 Id. 
82 Id. at 968. 
83 See James Muehlberger, Jennifer Stevenson & Madeleine McDonough, 
The Rise of Consumer Fraud Class Action Lawsuits Against Cosmetic Companies 
and Tips for Defending Them, WHO’S WHO LEGAL (June 2015), http://whoswho 
legal.com/news/features/article/32352/rise-consumer-fraud-class-action-lawsuits 
-against-cosmetic-companies-tips-defending-them [https://perma.cc/X9BR-GSB9]. 
84 See id. (discussing how primary jurisdiction doctrine and federal preemp-
tion may be used by defendants in cosmetic lawsuits to debunk plaintiffs’ claims). 
85 Elkind v. Revlon Consumer Prod. Corp., No. 14-CV-2484(JS)(AKT), 2015 
WL 2344134, at *1 (E.D.N.Y. May 14, 2015). 
86 Id. at *9 (quoting In re Medtronic, Inc., 623 F.3d 1200, 1204 (8th Cir. 2010)). 
87 Id.; see also 21 U.S.C. § 371 (granting regulatory enforcement of the FDCA 
to the FDA). 
88 Elkind, 2015 WL 2344134 at *9. 
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requires the resolution of issues which, under a regulatory scheme, 
have been placed within the special competence of an administra-
tive body.”89 The court moved to the merits of the plaintiffs’ decep-
tive advertising claims, reasoning that quick and inexpensive 
dispute resolution was more important than staying the proceed-
ings in order to allow the FDA to look at the contested phrase.90 
 This overview of recent suits brought in federal courts 
against cosmetic manufacturers for deceptive marketing demon-
strates the uncertainty surrounding such claims and the need for a 
more effective method of resolution.91 To create more consistent 
law on which lawyers may rely in the fields of cosmetic and beauty 
product litigation and to provide consumers with sufficient rem-
edies, consumer fraud actions brought against cosmetic manufac-
turers ought to be primarily replaced with Lanham Act lawsuits. 
The latter would be properly litigated by commercial competitors 
in the cosmetic industry for the purposes of increasing competition, 
diversifying suppliers, and ultimately benefitting consumers with 
transparency in the cosmetics market. 
II. LEGAL FRAMEWORK IN PLAY IN COSMETIC AND BEAUTY 
PRODUCT LITIGATION PRESENTLY APPLICABLE LAW 
A. Federal Food, Drug, & Cosmetic Act (FDCA) 
 When someone enters a retail shop with an intent to pur-
chase cosmetics, that consumer most likely assumes that the 
product he or she seeks is regulated and held to certain standards 
of health and safety in production.92 Apart from this general as-
sumption, the consumer probably knows very little about how cos-
metics are regulated, particularly in terms of whose responsibility it 
                                                                                                            
89 Id. (internal quotation marks and citation omitted). 
90 Id. But see Astiana v. Hain Celestial Grp., Inc., 783 F.3d 753, 762 (9th 
Cir. 2015) (affirming application of primary jurisdiction doctrine and staying a 
proceeding involving claims against cosmetic companies for fraudulent mar-
keting and use of the word “natural”). 
91 See Ebner v. Fresh, Inc., 838 F.3d 958, 962 (9th Cir. 2016); Elkind, 2015 
WL 2344134 at *9. 
92 See Senate Personal Care Product Safety Act of 2015, CAMPAIGN FOR SAFE 
COSMETICS, http://www.safecosmetics.org/get-the-facts/regulations/us-laws/ 
[https://perma.cc/34JR-2NNJ] (last visited Feb. 19, 2018). 
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is to regulate them and to what extent.93 The task of regulating 
cosmetics falls within the purview of the Food and Drug Admin-
istration, or FDA.94 The FDA enforces laws that Congress enacts 
and issues its own regulations upon receipt of authorization from 
Congress.95 Codified in Title 21 of the United States Code, the Fed-
eral Food, Drug, & Cosmetic Act is one of two primary statutory 
bases96 under which the FDA receives the rules it must enforce 
and the authority to enforce them.97 Under the FDCA, an article is 
a cosmetic if its purpose is to be “applied to the human body or 
any part thereof for cleansing, beautifying, promoting attractive-
ness, or altering the appearance.”98 This definition encompasses 
lipsticks, perfumes, skin moisturizers, nail polishes, eye and face 
makeup, cleansing shampoos, deodorants, and “any substance in-
tended for use as a component of a cosmetic product.”99 
 Notably, soap is not a cosmetic.100 While it would seem that 
soap “cleanses the appearance” and thus qualifies under the FDCA’s 
definition, products that meet the FDA’s definition of soap101 are 
regulated separately by the Consumer Product Safety Commis-
sion (CPSC).102 
                                                                                                            
93 See Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?), FOOD & DRUG ADMIN., 
https://www.fda.gov/Cosmetics/GuidanceRegulation/LawsRegulations/ucm07
4201.htm [https://perma.cc/JR6G-7KRC] (last updated Nov. 3, 2017) [hereinafter 
Is It a Cosmetic]. 
94 See Cosmetics, FOOD & DRUG ADMIN., http://www.fda.gov/Cosmetics/de 
fault.htm [https://perma.cc/69CG-PM8F] (last visited Feb. 19, 2018). 
95 See Cosmetics: Guidance and Regulation, FOOD & DRUG ADMIN., http:// 
www.fda.gov/Cosmetics/GuidanceRegulation/default.htm [https://perma.cc 
/MY7Q-LQTE] (last visited Feb. 19, 2018). 
96 The other is the Fair Packaging and Labeling Act (FPLA). See 15 U.S.C. 
§ 1451 (2012). 
97 See 21 U.S.C. § 321(i) (2012). 
98 Id. 
99 FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, 
but Are FDA-Regulated, FOOD & DRUG ADMIN. (2013), https://www.fda.gov 
/cosmetics/guidanceregulation/lawsregulations/ucm074162.htm [https://perma.cc 
/G8NJ-9S5A] [hereinafter FDA Authority]. 
100 Id. 
101 Is It a Cosmetic, supra note 93 (“FDA interprets the term ‘soap’ to apply 
only when the bulk of the nonvolatile matter in the product consists of an alkali 
salt of fatty acids and the product’s detergent properties are due to the alkali-fatty 
acid compounds, and the product is labeled, sold, and represented solely as soap” 
(quoting 21 C.F.R. § 701.20)). 
102 Id. 
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 The FDCA prohibits beauty product manufacturers from 
introducing “into interstate commerce” any cosmetic that is 
“adulterated or misbranded.”103 This section of the FDCA also 
distinctly prohibits the act of adulterating or misbranding the 
cosmetic itself.104 A cosmetic is considered adulterated if it “bears 
or contains any poisonous or deleterious substance which may 
render it injurious to users under the conditions of use pre-
scribed in the labeling thereof, or under such conditions of use as 
are customary or usual”105 whereas it is misbranded if “its label-
ing is false or misleading in any particular.”106 When a cosmetic is 
adulterated, the violation involves the product’s composition,107 
and a violation involving deceptive labeling or product packaging 
is a misbranding violation.108 
 Despite the above well-meaning definitions and sources of 
statutory authority, “regulation” and “approval” are not synon-
ymous.109 The former is an ex-post method for ensuring safety 
and efficiency in the marketplace.110 The latter is an ex-ante 
method of vetting a product’s suitability for use by consumers.111 
Lacking the legal authority to approve the safety of cosmetic 
products and ingredients before they are bought and sold in 
interstate commerce, the FDA has no way to forecast the poten-
tially deleterious effects of particular cosmetics and other personal 
care products.112 
                                                                                                            
103 21 U.S.C. § 331(a) (2012). 
104 Id. § 331(b). 
105 Id. § 361(a). 
106 Id. § 362(a). 
107 FDA Authority, supra note 99. 
108 Id. 
109 Id. In this context, a regulation is a governmental action taken to en-
sure a product’s suitability for consumption after it is released to the public, 
whereas an approval is the government’s permission granted before that product 
leaves the hands of its manufacturer and makes its way to the consumer. See id. 
110 See id. 
111 See id. 
112 See generally Cosmetics Basics, supra note 2 (“It is the responsibility of 
cosmetic manufacturers to ensure, before marketing their products, that the 
products are safe when used as directed in their label or under customary 
conditions of use.”). 
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B. Fair Packaging and Labeling Act (FPLA) 
 This Note’s principal argument is derived from the Supreme 
Court’s recent analysis of the FDCA in conjunction with the 
Lanham Act.113 As a result, the FDCA is the primary statute to 
understand when analyzing the issues inherent in cosmetic and 
beauty product litigation. It would be myopic, however, to ignore 
the relevance and importance of the Fair Packaging and Labeling 
Act (FPLA) when discussing the FDA’s regulation of cosmetics.114 
The FPLA is designed “to facilitate value comparisons and to pre-
vent unfair or deceptive packaging and labeling of many house-
hold ‘consumer commodities.’”115 The FPLA requires all cosmetics 
that are directly retailed to consumers to include an ingredient 
list.116 Cosmetics that are distributed solely for professional or 
institutional use are excluded from the ingredient list require-
ment, as are cosmetics that are distributed as free samples or 
hotel amenities.117 The FDCA considers any cosmetics that are 
noncompliant with the FPLA misbranded.118 
 Various proposals have been submitted to Congress with 
the help of non-profit organizations like the Campaign for Safe 
Cosmetics who “pressure the cosmetics industry to make safer 
products.”119 Both chambers of Congress introduced bills in 2015 
that would strengthen the protections of the Food, Drug, and 
Cosmetic Act.120 The latest action taken on the House’s bill was 
                                                                                                            
113 See POM Wonderful LLC v. Coca-Cola, Co., 134 S. Ct. 2228, 2233–34 (2014). 
114 See Fair Packaging and Labeling Act, 16 C.F.R. §§ 500–03 (2016). 
115 Fair Packaging and Labeling Act, FTC, https://www.ftc.gov/enforcement 
/rules/rulemaking-regulatory-reform-proceedings/fair-packaging-labeling-act 
[https://perma.cc/C54R-RDUU] (last visited Feb. 19, 2018). 
116 FDA Authority, supra note 99 (citing 21 C.F.R. § 701.3). 
117 See id. 
118 Id. (citing FPLA, § 1456). 
119 See About Us, CAMPAIGN FOR SAFE COSMETICS, http://www.safecosmetics 
.org/about-us/ [https://perma.cc/HE38-XKPJ] (last visited Feb. 19, 2018). Accord-
ing to their mission statement, the Campaign for Safe Cosmetics “works to protect 
the health of consumers, workers and the environment through public educa-
tion and engagement, corporate accountability and sustainability campaigns and 
legislative advocacy designed to eliminate dangerous chemicals linked to adverse 
health impacts from cosmetics and personal care products.” Id. 
120 The House of Representatives introduced the Cosmetic Modernization 
Amendments of 2015 in November 2015. H.R. 4075, 114th Cong. (2015). The bill 
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a referral to the subcommittee on Health in November 2015.121 As 
for the Senate’s bill, committee hearings were held in September 
2016.122 Given the slow-moving nature of legislation, many be-
lieve that the recent proposals are too ambitious to survive 
committee and become law.123 Given their repeated failure to 
survive committee, their feasibility remains suspect without “a 
monumental shift in public awareness and pressure” about the 
issue.124 Presumably, the type of public awareness that is needed 
is general knowledge about the potential health impacts of 
harmful ingredients.125 Supporters of increased cosmetic indus-
try regulation further suggest that the public would benefit from 
knowing the extent to which the FDA cannot regulate cosmet-
ics—the premise of their argument is that an agency which can-
not regulate certain products necessarily lacks knowledge about 
                                                                                                            
amends the FDCA to “set forth provisions governing the [FDA’s] regulation of 
cosmetics including requiring the registration of manufacturing establishments 
and the submission of a cosmetic and ingredient statement for each cosmetic.” 
Summary: H.R. 4075—114th Cong., CONGRESS.GOV, https://www.congress.gov/bill 
/114th-congress/house-bill/4075?q=%7B%22search%22%3A%5B%22food+drug 
+and+cosmetic%22%5D%7D&resultIndex=28 [https://perma.cc/3ZEF-UKMF] 
(last visited Feb. 19, 2018). The Senate introduced a bill with similar aims, called 
the Personal Care Products Safety Act, in April 2015. S. 1014, 114th Cong. (2015). 
The bill amends the FDCA to give the FDA authority to prohibit distribution of a 
cosmetic if it finds that cosmetic has “a reasonable probability of causing serious 
adverse health consequences.” Summary: S.1014—114th Cong., CONGRESS.GOV, 
https://www.congress.gov/bill/114th-congress/senate-bill/1014?q=%7B%22search 
%22%3A%5B%22food+drug+and+cosmetic%22%5D%7D [https://perma.cc/N5P6 
-CZ73] (last visited Feb. 19, 2018). Furthermore, under this bill, cosmetic com-
panies are required to report “any serious adverse event associated with such 
cosmetic product” to the FDA. S. 1014, 114th Cong. § 104 (2015). 
121 Cosmetic Modernization Amendments of 2015, H.R. 4075, 114th Cong. 
(2015). 
122 Summary: S.1014—114th Cong., supra note 120 (noting when the latest 
action was taken on this bill). 
123 See Valerie J. Watnick, The Missing Link: U.S. Regulation of Consumer 
Cosmetic Products to Protect Human Health and the Environment, 31 PACE 
ENVTL. L. REV. 595, 648 (2014); see also Janet Nudelman, Federal Personal Care 
Products Safety Act (S.1014), CAMPAIGN FOR SAFE COSMETICS (May 28, 2015), 
http://www.safecosmetics.org/wp-content/uploads/2015/06/Personal-Care-Products 
-Safety-Act-SB-1014-factsheet.pdf [https://perma.cc/7XTK-LFS4]. 
124 Watnick, supra note 123, at 649. 
125 See U.S. Laws: FDA’s Lack of Authority, supra note 5. 
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those products. Without knowledge, the agency cannot effectively 
shield consumers from potential harms the way they ordinarily 
would through enforcement of a regulatory scheme.126 
C. Section 43(a) of the Lanham Act 
  Yet another critical federal law relevant to cosmetic litiga-
tion, and litigation in all commercial industries, is the Lanham 
Act.127 The Lanham Act is found under Title 15 of the United 
States Code—the Code’s chapter on Commerce and Trade.128 Sec-
tion 45 of the Act provides its purpose, that is, in part, “to regulate 
commerce within the control of Congress” and “to protect persons 
engaged in such commerce against unfair competition.”129 At its 
inception, the Lanham Act was primarily a trademark regula-
tion statute, later becoming useful as a safeguard for commer-
cial competitors against unfair business practices and unfair 
competition.130 Unfair competition is an umbrella term in this 
context which encompasses two, sub-categorical business prac-
tices: false association and false advertising.131 Of the two, false 
advertising is the practice relevant to the cosmetic industry and 
its manufacturers who can use the law to uncover and enjoin 
deceptive business practices employed by their competitors.132 
 The Lanham Act imposes civil liability on any person who 
misrepresents the content or quality of goods or services in com-
mercial advertising or promotion.133 Of important note is the fact 
that consumer standing is limited under the Act; circuit courts con-
tinually conclude that § 43(a) is intended only for use by plaintiffs 
with a commercial interest in need of protection from injurious 
                                                                                                            
126 See id. 
127 See generally Lanham Act, 15 U.S.C. § 1051 (2012). 
128 See id. 
129 Lanham Act § 45(a), 15 U.S.C. § 1127 (2012). 
130 See James S. Wrona, False Advertising and Consumer Standing Under 
Section 43(a) of the Lanham Act: Broad Consumer Protection Legislation or a 
Narrow Pro-Competitive Measure?, 47 RUTGERS L. REV. 1085, 1091–92 (1995). 
131 See id. at 1091 (citing Rosenfeld v. W.B. Saunders, 728 F. Supp. 236, 
241–42 (S.D.N.Y. 1990)). 
132 False association involves “the selling of one’s goods or services under 
the name of a more popular competitor.” Rosenfeld, 728 F. Supp., at 241. False 
association cosmetic litigation is not discussed in this Note. 
133 Lanham Act § 43(a), 15 U.S.C § 1125(a)(1)(B) (2012). 
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business practices.134 In short, the Act is best understood as a 
“pro-competitive measure rather then [sic] an all-encompassing 
consumer protection device.”135 The Ninth Circuit, for example, 
where much of the beauty product and cosmetic litigation ensues,136 
articulated its own test for standing under the Lanham Act in the 
early 1990s.137 There, plaintiffs are required to show a competitive 
injury when alleged liability is based on the false advertising 
subcategory of unfair competition.138 That parties must be com-
mercial competitors in order to sue under the Lanham Act in the 
Ninth Circuit is beneficial for niche and entrepreneurial cosmetic 
companies. Those companies can use the Lanham Act as a means 
to compete against industry behemoths whose presence in the 
market is inescapable, and whose ill-gotten business practices 
are difficult to track before products hit the shelves.139 
 The trend of limiting standing under § 43(a) of the Lanham 
Act has continued in federal courts, most likely because judges 
do not want their dockets clogged with false advertising cases 
unless the competitive injury asserted by one business is suffi-
ciently linked to the misrepresentations of another such that 
judicial intervention is warranted.140 In accordance with the Ninth 
Circuit’s approach, courts deem a Lanham Act plaintiff’s status 
as a commercial competitor of the named defendant(s) the most 
important consideration.141 
                                                                                                            
134 See generally Wrona, supra note 130, at 1133. 
135 Id. 
136 See, e.g., Brown v. Hain Celestial Grp., Inc., 913 F. Supp. 2d 881, 884 
(N.D. Cal. 2012); Ebner v. Fresh, Inc., 838 F.3d 958, 958 (9th Cir. 2016); Astiana 
v. Hain Celestial Grp., Inc., 783 F.3d 753, 756 (9th Cir. 2015). 
137 Wrona, supra note 130, at 1135. 
138 Id. (discussing the Ninth Circuit’s treatment of Lanham Act standing 
in Waits v. Frito-Lay, Inc., 978 F.2d 1093 (9th Cir. 1992)). 
139 See Weinberger, Wagner & Jacoby, supra note 12 (“[Lanham Act] suits 
are an effective means not only to protect a company’s business interests, but 
also to compete for and maintain market share.”). 
140 See John E. Villafranco & Matthew D. Marcotte, Unfair Competition in 
Advertising: Developments and Trends in Lanham Act Litigation, 22 ANTITRUST 
98, 99 (2008). 
141 Id. (“[C]ourts are continuing to express skepticism about expansive standing 
under the Lanham Act, especially where customers or suppliers, rather than 
competitors, attempt to bring false advertising actions under Section 43(a).”). 
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D. Applying the Supreme Court’s Holding in POM Wonderful to 
Cosmetic and Beauty Product Litigation 
 In 2014, the Supreme Court of the United States heard the 
case of POM Wonderful LLC v. Coca-Cola Co.142 The Court granted 
certiorari to decide whether POM Wonderful’s false advertising 
claim against Coca-Cola Co. brought under § 43(a) of the Lanham 
Act was precluded by the FDCA.143 POM Wonderful alleged that 
Coca-Cola’s use of the words “Pomegranate Blueberry” on its labels 
was “false and misleading” because the product did not in fact 
contain juices from those fruits.144 Coca-Cola responded, arguing 
for dismissal because its labels complied with all relevant food 
and beverage regulations of the FDCA.145 After providing an ex-
tensive discussion of the two federal statutes, the Court reversed 
the Ninth Circuit’s holding146 and held that the FDA’s enforcement 
of the FDCA does not preempt false advertising or unfair compe-
tition claims brought by commercial competitors under the Lanham 
Act.147 Rather, to defend their interests, competitors may bring such 
claims under § 43(a) of the Lanham Act, and those claims are prop-
erly viewed as complements (not conflicts) to the FDA’s enforce-
ment of the FDCA.148 Noting first that the Lanham Act and the 
FDCA have separate purposes,149 and further that the FDA and 
marketplace competitors have different areas of expertise, the 
Court reasoned: 
                                                                                                            
142 POM Wonderful LLC v. Coca-Cola Co., 134 S. Ct. 2228 (2014). 
143 Id. at 2236. 
144 See Maia H. Harris, Fred Kelly, Jr. & Charles Dell’Anno, Looking at 
Lanham Act Claims Against Drug Cos. Post-Pom, LAW360 (Oct. 27, 2014, 
4:08 PM), https://www.law360.com/articles/590374/looking-at-lanham-act-claims 
-against-drug-cos-post-pom [https://perma.cc/AK52-NFXF]. 
145 Id. 
146 The Ninth Circuit Court of Appeals held that POM Wonderful’s Lanham 
Act claim against Coca-Cola was barred by the FDCA because in promulgating 
the FDCA, Congress intended to provide national uniformity in food and beverage 
labeling, enforced by the FDA. See POM Wonderful LLC v. Coca-Cola Co., 679 
F.3d 1170, 1178–79 (9th Cir. 2012). 
147 POM Wonderful, 134 S. Ct. at 2237–39. 
148 Id. at 2238. 
149 Id. at 2240. 
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Enforcement of the FDCA and the detailed prescriptions of its 
implementing regulations is largely committed to the FDA. 
The FDA, however, does not have the same perspective or ex-
pertise in assessing market dynamics that day-to-day competi-
tors possess. Competitors who manufacture or distribute products 
have detailed knowledge regarding how consumers rely upon 
certain sales and marketing strategies. Their awareness of unfair 
competition practices may be far more immediate and accu-
rate than that of agency rulemakers and regulators. Lanham 
Act suits draw upon this market expertise by empowering 
private parties to sue competitors to protect their interests on 
a case-by-case basis. By “serv[ing] a distinct compensatory 
function that may motivate injured persons to come forward,” 
Lanham Act suits, to the extent they touch on the same subject 
matter as the FDCA, “provide incentives” for manufacturers to 
behave well.150 
 The Supreme Court, in recognizing the ways in which a 
Lanham Act lawsuit can incentivize good behavior on the part of 
manufacturers, focused exclusively on the product labeling 
choices of food and beverage manufacturers.151 However, at least 
one subsequent federal district court decision held that “POM’s 
general presumption in favor of the permissibility of Lanham 
Act claims applies to all products regulated by the FDCA.”152 
 Following that district court’s reasoning, the Supreme 
Court’s relaxation of Lanham Act claims in POM Wonderful 
should extend to claims involving cosmetics.153 This contention 
is further supported by federal district courts that have ruled, 
after POM Wonderful, that commercial “competitors may bring 
Lanham Act claims challenging product labels for a variety of prod-
ucts regulated by different federal administrative agencies.”154 
                                                                                                            
150 Id. at 2238–39. 
151 Id. at 2233. 
152 Stephen White, How Far Does the Apple (Pomegranate) Fall From the Tree? 
Preclusion of Lanham Act Claims by the Food, Drug, & Cosmetic Act and POM 
Wonderful LLC v. Coca-Cola Co., 15 WAKE FOREST J. BUS. & INTELL. PROP. L. 262, 
284 (2015) (discussing JHP Pharm., LLC, v. Hospira, Inc., No. CV 13-07460, 
2014 WL 4988016, at *5). 
153 See id. at 282–84. 
154 Matthew Busch, POM Wonderful v. Coca-Cola and the Implications of 
Granting Competitors the Right to Challenge False or Misleading Food and 
Beverage Labels Under the Lanham Act, 48 LOY. L.A.L. REV. 525, 534 (Winter 
2014) (citing Catheter Connections, Inc. v. Ivera Medical Corp., No. 2:14-CV 
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 Assuming POM Wonderful applies in the context of cos-
metic litigation, the next logical step is to analyze whether its 
use in those cases will incentivize better behavior from the in-
dustry’s largest manufacturers, and thus create a path to more 
perfect competition in the cosmetic marketplace. 
III. RESISTING THE STATUS QUO IN COSMETIC AND BEAUTY PRODUCT 
LITIGATION: HOW THE LANHAM ACT ACHIEVES EFFICIENCY BY 
PRESERVING COMMERCIAL INTEGRITY IN THE COSMETIC INDUSTRY 
 
 Small cosmetic companies, particularly those offering a 
specialty product(s), could benefit from using the Lanham Act to 
advance their business interests and to uncover a market-based 
intolerance for their competitors’ unfair businesses practices. After 
the Supreme Court’s decision in POM Wonderful, scholars specu-
lated that litigation for deceptive labeling would increase because 
product labels that comply with the FDA’s requirements are no 
longer enough to keep manufacturers insulated from liability.155 
 A company like LUSH Cosmetics, which crafts each of its 
products by hand in small batches,156 cannot equitably compete 
with an industry juggernaut that uses mostly machine manufactur-
ing but that inattentively labels its products with words that evoke 
images of conscientious, LUSH-like manufacturing practices.157 
A small cosmetic company that uses the Lanham Act to assert a 
claim against a larger cosmetic company would rely on theories 
of false advertising or unfair competition.158 The hypothetical 
situation is one where the plaintiff cosmetic company sues for 
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commercial injury to reputation or sales proximately caused by 
the defendant cosmetic company’s allegedly false or misleading 
use of marketing terms. 
 One weakness with this kind of lawsuit is that it requires 
courts to inquire into consumers’ minds to determine how they 
define certain, legally undefined terms when they make their cos-
metic purchases.159 While this type of guesswork is not ideal, it is 
necessary because cosmetic companies commonly use terms such as 
“natural,” “organic,” or “hypoallergenic” in their marketing, all of 
which are undefined by the FDA.160 Proving that a defendant’s mar-
keting claim is false, misleading, and actually deceptive or likely 
to be deceptive appears to be an insurmountable hurdle for plain-
tiffs because so many of these terms lack concrete definitions.161 
 For example, the plaintiff would struggle to position itself 
as the superior manufacturer using uncontrived processes and 
ingredients without some established criteria from which it fol-
lows that the defendant’s manufacturing processes and ingredi-
ents are unnatural. 
 This weakness, however, is not fatal.162 Despite the FDA’s 
decision not to define the term “natural” as it is used in the market-
ing of cosmetics,163 the Federal Trade Commission (FTC) has issued 
several orders to cosmetic companies which prohibit products con-
taining synthetic ingredients from being misrepresented to con-
sumers as “all-natural.”164 By condemning cosmetic companies 
that haphazardly use the FDA’s undefined term, the FTC has made 
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it easier for potential plaintiffs in cosmetic Lanham Act suits to 
satisfy the elements of a false advertising claim under § 43(a).165 
 A trip to the drug store to purchase mascara ought not to be 
an esoteric experience for consumers.166 Consumers are entitled to 
rely on words like “natural” when they see them on a cosmetic’s 
label.167 The difficulties that may arise when it comes to proving 
damages in these cosmetic Lanham Act lawsuits168 should not be 
ignored, but, given the market research that exists on consumer 
preferences and cosmetic revenues,169 economic harms suffered by 
a pool of commercial litigants could likely be shown more con-
cretely than physical harms which have previously been alleged by 
individual consumers and met with suspicion and inadequate re-
dress from courts.170 
 The Supreme Court acknowledged in POM Wonderful that 
consumers benefit from the Lanham Act’s proper enforcement.171 
By prohibiting false and misleading advertising, the Lanham Act 
aims to incentivize manufacturers into producing higher quality 
commodities that can be marketed profitably and truthfully.172 
 The pace of innovation in the cosmetic industry has rapidly 
increased over the last decade, fostering today’s competitive busi-
ness climate.173 There is nothing so damaging to competition as 
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“a competitor’s false advertising campaign.”174 To illustrate unfair 
competition in a business market rife with false or misleading 
advertising, consider a simple illustration: Company A produces 
products by hand and concentrates its efforts on sourcing fresh 
ingredients of the highest quality from organic orchards.175 
Company B adds chemicals and other artificial ingredients to their 
lab-created products and yet markets them using the same words 
as Company A but can charge less than Company A because its 
product required less labor to produce.176 The average consumer, 
relying only on what he or she knows of linguistics, will purchase 
Company B’s more affordable option (having no reason to know 
that the words on its label are virtually meaningless) and the 
company with false advertising practices will come out on top.177 
If that consumer brings a colorable claim of false advertising 
against Company B in the future, then Company B’s use of dis-
honest marketing will have supported a market inefficiency, or a 
“breakdown of buyer-seller communications [that] leads to gaps 
in publicly available demand and supply information acerbated 
by current prices that do not reflect [the] true situation.”178 
 A successful Lanham Act suit provides an immediate in-
junction proscribing a competitor’s intrusive and misleading pro-
motional statements.179 In some cases, Lanham Act plaintiffs 
may obtain this equitable remedy in the lawsuit’s preliminary 
stages, just weeks after commencing suit.180 To the contrary, 
remedies provided by the state consumer protection statutes 
that are ordinarily relied upon by cosmetic and beauty product 
litigation plaintiffs tend to be less immediate and less effective 
when it comes to deterring and redressing national harms caused 
by false advertising.181 
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 The only alternative forum for commercial competitors 
seeking a remedy for business harms caused by false advertising 
is the National Advertising Division of the Council of Better 
Business Bureaus (NAD).182 NAD proceedings are both volun-
tary and non-binding, and decisions resulting therefrom are 
unenforceable by courts.183 Given the severe limitations posed by 
NAD proceedings, a Lanham Act suit appears to be a more effi-
cient course of action when a competitor’s advertising efforts 
threaten a cosmetic company’s bottom line.184 
 Furthermore, cosmetic manufacturers with expertise and 
familiarity about their goods are better equipped than consum-
ers to bear the costs of taking extra precautions or reducing ex-
pected harms.185 Armed with the revenue capital and “know-how” 
necessary to make the industry safer and more efficient, manu-
facturers, not consumers, ought to be the plaintiffs in cases of 
cosmetic and beauty product litigation.186 
 Even though consumers who are actually harmed by cos-
metics are only indirectly benefitted by this proposed solution, 
the banding together of small cosmetic companies under the 
Lanham Act is the industry’s most viable option for regulatory 
reform that will preserve industry leaders’ independence while 
answering consumers’ call for increased oversight.187 Given the 
dearth of regulation at the administrative level,188 and the trend 
toward dismissing consumer complaints in the judiciary,189 this 
indirect remedy is better than no remedy at all. 
CONCLUSION 
 It is not too much to suggest that most Americans, in 
their roles as consumers of beauty culture, prefer not to make 
independent decisions about what makes a certain appearance 
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beautiful.190 Similarly, in their roles as consumers of cosmetics, 
Americans prefer not to make independent judgments about the 
potential harmfulness of a product or the legitimacy of its adver-
tising.191 This is no new phenomenon.192 
 Everyday consumers prefer to have those credited with 
experience and knowledge in the fields of health and beauty decide 
for them what looks good and what is good for them.193 This del-
egation of decision-making power can become economically inef-
ficient or even harmful when the decision-makers neglect their 
duties or, worse yet, carry out their duties dishonestly.194 
 By using the Lanham Act to regulate the cosmetic indus-
try, consumers of cosmetics and their counterparts who work in 
a manufacturing capacity can benefit from a more competitive 
marketplace that offers more of what consumers want—consciously 
manufactured cosmetics.195 
 After the Supreme Court’s decision to expand Lanham 
Act liabilities and uses in POM Wonderful, and assuming courts 
will continue to interpret that decision as applying outside of the 
food and beverage industry to cosmetic and beauty product liti-
gation, cosmetic manufacturers who are mindful of their consumers’ 
health and wellness demands and focused on creating sustainable 
products have an opportunity to contend in a market economy 
against their larger and more readily recognizable competitors.196 
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